|
|
||||||||
Review |
Service de Réanimation Médicale, Nancy, France
Service de Réanimation Médicale, Nancy, France
REPRINT REQUESTS: Sébastien Gibot, MD, Service de Réanimation Médicale, 29 avenue du Maréchal de Latttre de Tassigny, 54000 Nancy, France, Telephone: +33-3-83852970, Fax: +33-3-83858511, Email: s.gibot{at}chu-nancy.fr
Sepsis is a common cause of morbidity and mortality in intensive care units. Unfortunately, there is no gold standard for diagnosing sepsis as clinical and laboratory signs are neither sensitive enough nor specific enough, and microbiological studies often remain negative. Thus, there is a need for clinical or laboratory tools to distinguish between sepsis and non-infectious inflammatory disorders. Among the potentially useful markers of sepsis, procalcitonin has been suggested to be the most promising, although results are variable depending on the severity of illness and degree of infection in the patient population studied. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, of which expression is upregulated on phagocytic cells in the presence of bacteria or fungi. Here we report on the potential usefulness of assessing the soluble form of TREM-1 (sTREM-1) in biological fluids for the diagnosis of microbial infection.
Key Words: Sepsis Infection Community-acquired infections Membrane glycoproteins C-reactive protein Protein precursors Predictive value of tests Inflammation/diagnosis
This article has been cited by other articles:
![]() |
M. Ornatowska, A. C. Azim, X. Wang, J. W. Christman, L. Xiao, M. Joo, and R. T. Sadikot Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1377 - L1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gomez-Pina, A. Soares-Schanoski, A. Rodriguez-Rojas, C. del Fresno, F. Garcia, M. T. Vallejo-Cremades, I. Fernandez-Ruiz, F. Arnalich, P. Fuentes-Prior, and E. Lopez-Collazo Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes J. Immunol., September 15, 2007; 179(6): 4065 - 4073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christ-Crain and B. Muller Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur. Respir. J., September 1, 2007; 30(3): 556 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haselmayer, L. Grosse-Hovest, P. von Landenberg, H. Schild, and M. P. Radsak TREM-1 ligand expression on platelets enhances neutrophil activation Blood, August 1, 2007; 110(3): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Fortin, O. Lesur, and T. Fulop Jr Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4 Int. Immunol., January 1, 2007; 19(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Netea, T. Azam, G. Ferwerda, S. E. Girardin, S.-H. Kim, and C. A. Dinarello Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors J. Leukoc. Biol., December 1, 2006; 80(6): 1454 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gattis, A. V. Washington, M. M. Chisholm, L. Quigley, A. Szyk, D. W. McVicar, and J. Lubkowski The Structure of the Extracellular Domain of Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 and Evidence for a Naturally Occurring Soluble Fragment J. Biol. Chem., May 12, 2006; 281(19): 13396 - 13403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Bianchin, J. E. Lima, J. Natel, A. C. Sakamoto, H. Klunemann, B.H. Ridha, L. Magy, J.R. Wherrett, D.M. Hemelsoet, R.W. Keen, et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2 Neurology, February 28, 2006; 66(4): 615 - 616. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |